3 completed, 1 withdrawn. 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow CoAxia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke NeuroFlo - Acute Stroke | Phase 1 | Withdrawn | University of California, Los Angeles | 2008-03-01 | 2017-01-12 | |
| Feasibility and Safety of NeuroFlo in Stroke Patients Receiving Tissue Plasminogen Activator NeuroFlo catheter - Ischemic Stroke | Phase 1 | Completed | CoAxia | 22 | 2007-05-01 | 2010-03-11 |
| Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients NeuroFlo™ Catheter - Cerebrovascular Accident | Phase 1 | Completed | CoAxia | 26 | 2007-02-01 | 2009-02-05 |
| Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) NeuroFlo™ catheter, Control - Cerebrovascular Accident | Phase 3 | Completed | CoAxia | 515 | 2005-06-01 | 2011-05-18 |
Stroke (3) · Ischemia (2) · Ischemic Stroke (1)
Canada (3) · Germany (3) · United States (3) · Switzerland (2) · Austria (1) · Belgium (1) · Hungary (1) · Israel (1) · Puerto Rico (1) · Spain (1)
Ashfaq Shuaib, MD (1) · David S. Liebeskind, M.D. (1) · Sidney Starkman, M.D. (1)
PMID 21350210, PMID 21566232, PMID 22264202, PMID 23291425, PMID 23549132, PMID 23828106